Status:
RECRUITING
Long-Term Outcomes of LAA Contrast Flow in CT Scans After Endocardial LAA Closure: The CF-CT Registry
Lead Sponsor:
Kansas City Heart Rhythm Research Foundation
Conditions:
Atrial Fibrillation
Ischemic Stroke, Acute
Eligibility:
All Genders
18+ years
Brief Summary
This study is intended to assess the incidence and correlation to the development of peri-device leaks (PDLs), device related thrombosis (DRTs) and cerebral vascular accident (CVA)/transient ischemic ...
Detailed Description
Although the clinical significance of long-term left atrial appendage contrast flow (LAA-CF) in computerized tomography (CT) scan is unknown, study by Lim et al reported that 45 days are not enough fo...
Eligibility Criteria
Inclusion
- Subjects must be at least 18 years of age.
- Subjects underwent LAA closure with Watchman/Watchman FLX or Amplatzer Amulet at our institution from January 2019 till June 2022
Exclusion
- No definite exclusion criteria are defined for the study as all patients with Watchman-FLX or Amplatzer Amulet will be included in the study.
Key Trial Info
Start Date :
July 24 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06075628
Start Date
July 24 2023
End Date
December 1 2025
Last Update
August 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kansas City Heart Rhythm Institute
Overland Park, Kansas, United States, 66211